Foliglurax Failed in Trial to Ease Side Effects of Long-term Levodopa
In a final report on the Phase 2 AMBLED trial, scientists detailed the failure of Foliglurax (PTX002331) — once…
Articles by Steve Bryson, PhD
Aripiprazole at Low Dose Eases Parkinson’s Psychosis, If Tolerable
A low daily dose of aripiprazole, an antipsychotic therapy, significantly eased hallucinations and delusions in people with Parkinson’s disease and…
Anonymous Survey Shows Cannabis Use by 11.3% of Patients in Norway
In an anonymous online survey, 11.3% of Norwegian adults with Parkinson’s disease revealed current or previous use of cannabis…
Analyzing Finger Taps, Voice on Cellphone May Help in Diagnosis
Collecting finger tapping, voice, and walking data on a smartphone to be digitally processed by deep machine learning tools can…
Intestinal Bacteria Not Seen to Affect Duodopa (Duopa) Blood Levels
The presence of levodopa-metabolizing bacteria in the intestines of adults using Duodopa (Duopa in the U.S.) to treat their…
Mannitol Safe But Not Likely to Treat Parkinson’s Symptoms, Trial Reports
Although safe and fairly well tolerated, treatment with the over-the-counter supplement mannitol did not lessen symptoms in adults with…
Development Halted on Gene Therapy Candidate AXO-Lenti-PD
Sio Gene Therapies (Sio), formerly known as Axovant, intends to stop  development of AXO-Lenti-PD, an investigational gene therapy…
MJFF Urges US Veterans’ Affairs to Better Fund Disease Care, Research
The Michael J. Fox Foundation (MJFF) encouraged the U.S. House of Representatives’ Committee on Veterans’ Affairs to expand healthcare…
Treatments for Rheumatoid Arthritis Don’t Appear to Prevent Parkinson’s
Medications used to treat rheumatoid arthritis, an autoimmune disorder, do not affect a person’s risk of developing Parkinson’s disease,…
Psychosis Common With Late-stage Parkinson’s, Study Reports
Psychosis, including hallucinations and delusions, is frequent in people with late-stage Parkinson’s disease a study reported, after psychotic symptoms were…